1. Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. (15th July 2019) Authors: Weisberg, Ellen; Meng, Chengcheng; Case, Abigail E.; Sattler, Martin; Tiv, Hong L.; Gokhale, Prafulla C.; Buhrlage, Sara J.; Liu, Xiaoxi; Yang, Jing; Wang, Jinhua; Gray, Nathanael; Stone, Richard M.; Adamia, Sophia; Dubreuil, Patrice; Letard, Sebastien; Griffin, James D. Journal: British journal of haematology Issue: Volume 187:Number 4(2019) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology. Issue 1 (December 2017) Authors: Hammam, Kahina; Saez-Ayala, Magali; Rebuffet, Etienne; Gros, Laurent; Lopez, Sophie; Hajem, Berengere; Humbert, Martine; Baudelet, Emilie; Audebert, Stephane; Betzi, Stephane; Lugari, Adrien; Combes, Sebastien; Letard, Sebastien; Casteran, Nathalie; Mansfield, Colin; Moussy, Alain; De Sepulveda, ... Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗